img

Global Duck Vaccines Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Duck Vaccines Market Research Report 2024

Vaccination is commonly used in commercial duck and increasingly in backyard birds to control disease.
According to Mr Accuracy reports new survey, global Duck Vaccines market is projected to reach US$ 551.9 million in 2029, increasing from US$ 375 million in 2022, with the CAGR of 5.6% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Duck Vaccines market research.
The duck vaccines market is witnessing steady growth due to the increasing demand for duck meat and the rising prevalence of avian diseases in duck populations. Duck vaccines play a vital role in preventing and controlling viral and bacterial diseases in ducks. The market is driven by factors such as the growth of the duck farming industry, rising consumer preference for duck products, and the need for effective disease management strategies. Advancements in vaccine development and technology, such as the availability of recombinant vaccines and improved vaccination techniques, are further fueling market growth. However, challenges such as the limited availability of specific duck vaccines for certain diseases and the high costs associated with vaccine procurement and administration may hinder market expansion. With the continuous focus on improving duck health, biosecurity measures, and sustainable duck farming practices, the duck vaccines market is expected to witness sustained growth in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Duck Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Boehringer Ingelheim
CEVA
CAHIC
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
Zoetis
Elanco
FATRO
CAVAC
Vaksindo
Segment by Type
Attenuated Live Vaccines
Killed Vaccines

Segment by Application


Avian Influenza Vaccine
Newcastle Disease Vaccine
Other

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Duck Vaccines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Duck Vaccines Market Overview
1.1 Product Overview and Scope of Duck Vaccines
1.2 Duck Vaccines Segment by Type
1.2.1 Global Duck Vaccines Market Value Comparison by Type (2024-2034)
1.2.2 Attenuated Live Vaccines
1.2.3 Killed Vaccines
1.3 Duck Vaccines Segment by Application
1.3.1 Global Duck Vaccines Market Value by Application: (2024-2034)
1.3.2 Avian Influenza Vaccine
1.3.3 Newcastle Disease Vaccine
1.3.4 Other
1.4 Global Duck Vaccines Market Size Estimates and Forecasts
1.4.1 Global Duck Vaccines Revenue 2018-2029
1.4.2 Global Duck Vaccines Sales 2018-2029
1.4.3 Global Duck Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Duck Vaccines Market Competition by Manufacturers
2.1 Global Duck Vaccines Sales Market Share by Manufacturers (2018-2024)
2.2 Global Duck Vaccines Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Duck Vaccines Average Price by Manufacturers (2018-2024)
2.4 Global Duck Vaccines Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Duck Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Duck Vaccines, Product Type & Application
2.7 Duck Vaccines Market Competitive Situation and Trends
2.7.1 Duck Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Duck Vaccines Players Market Share by Revenue
2.7.3 Global Duck Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Duck Vaccines Retrospective Market Scenario by Region
3.1 Global Duck Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Duck Vaccines Global Duck Vaccines Sales by Region: 2018-2029
3.2.1 Global Duck Vaccines Sales by Region: 2018-2024
3.2.2 Global Duck Vaccines Sales by Region: 2024-2029
3.3 Global Duck Vaccines Global Duck Vaccines Revenue by Region: 2018-2029
3.3.1 Global Duck Vaccines Revenue by Region: 2018-2024
3.3.2 Global Duck Vaccines Revenue by Region: 2024-2029
3.4 North America Duck Vaccines Market Facts & Figures by Country
3.4.1 North America Duck Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Duck Vaccines Sales by Country (2018-2029)
3.4.3 North America Duck Vaccines Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Duck Vaccines Market Facts & Figures by Country
3.5.1 Europe Duck Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Duck Vaccines Sales by Country (2018-2029)
3.5.3 Europe Duck Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Duck Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Duck Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Duck Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Duck Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Duck Vaccines Market Facts & Figures by Country
3.7.1 Latin America Duck Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Duck Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Duck Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Duck Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Duck Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Duck Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Duck Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Duck Vaccines Sales by Type (2018-2029)
4.1.1 Global Duck Vaccines Sales by Type (2018-2024)
4.1.2 Global Duck Vaccines Sales by Type (2024-2029)
4.1.3 Global Duck Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Duck Vaccines Revenue by Type (2018-2029)
4.2.1 Global Duck Vaccines Revenue by Type (2018-2024)
4.2.2 Global Duck Vaccines Revenue by Type (2024-2029)
4.2.3 Global Duck Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Duck Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Duck Vaccines Sales by Application (2018-2029)
5.1.1 Global Duck Vaccines Sales by Application (2018-2024)
5.1.2 Global Duck Vaccines Sales by Application (2024-2029)
5.1.3 Global Duck Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Duck Vaccines Revenue by Application (2018-2029)
5.2.1 Global Duck Vaccines Revenue by Application (2018-2024)
5.2.2 Global Duck Vaccines Revenue by Application (2024-2029)
5.2.3 Global Duck Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Duck Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Duck Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Boehringer Ingelheim Duck Vaccines Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 CEVA
6.2.1 CEVA Corporation Information
6.2.2 CEVA Description and Business Overview
6.2.3 CEVA Duck Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.2.4 CEVA Duck Vaccines Product Portfolio
6.2.5 CEVA Recent Developments/Updates
6.3 CAHIC
6.3.1 CAHIC Corporation Information
6.3.2 CAHIC Description and Business Overview
6.3.3 CAHIC Duck Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.3.4 CAHIC Duck Vaccines Product Portfolio
6.3.5 CAHIC Recent Developments/Updates
6.4 Ringpu Biology
6.4.1 Ringpu Biology Corporation Information
6.4.2 Ringpu Biology Description and Business Overview
6.4.3 Ringpu Biology Duck Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Ringpu Biology Duck Vaccines Product Portfolio
6.4.5 Ringpu Biology Recent Developments/Updates
6.5 Yebio
6.5.1 Yebio Corporation Information
6.5.2 Yebio Description and Business Overview
6.5.3 Yebio Duck Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Yebio Duck Vaccines Product Portfolio
6.5.5 Yebio Recent Developments/Updates
6.6 Harbin Veterinary Research Institute
6.6.1 Harbin Veterinary Research Institute Corporation Information
6.6.2 Harbin Veterinary Research Institute Description and Business Overview
6.6.3 Harbin Veterinary Research Institute Duck Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Harbin Veterinary Research Institute Duck Vaccines Product Portfolio
6.6.5 Harbin Veterinary Research Institute Recent Developments/Updates
6.7 Merck Animal Health
6.6.1 Merck Animal Health Corporation Information
6.6.2 Merck Animal Health Description and Business Overview
6.6.3 Merck Animal Health Duck Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Merck Animal Health Duck Vaccines Product Portfolio
6.7.5 Merck Animal Health Recent Developments/Updates
6.8 Zoetis
6.8.1 Zoetis Corporation Information
6.8.2 Zoetis Description and Business Overview
6.8.3 Zoetis Duck Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Zoetis Duck Vaccines Product Portfolio
6.8.5 Zoetis Recent Developments/Updates
6.9 Elanco
6.9.1 Elanco Corporation Information
6.9.2 Elanco Description and Business Overview
6.9.3 Elanco Duck Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Elanco Duck Vaccines Product Portfolio
6.9.5 Elanco Recent Developments/Updates
6.10 FATRO
6.10.1 FATRO Corporation Information
6.10.2 FATRO Description and Business Overview
6.10.3 FATRO Duck Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.10.4 FATRO Duck Vaccines Product Portfolio
6.10.5 FATRO Recent Developments/Updates
6.11 CAVAC
6.11.1 CAVAC Corporation Information
6.11.2 CAVAC Duck Vaccines Description and Business Overview
6.11.3 CAVAC Duck Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.11.4 CAVAC Duck Vaccines Product Portfolio
6.11.5 CAVAC Recent Developments/Updates
6.12 Vaksindo
6.12.1 Vaksindo Corporation Information
6.12.2 Vaksindo Duck Vaccines Description and Business Overview
6.12.3 Vaksindo Duck Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Vaksindo Duck Vaccines Product Portfolio
6.12.5 Vaksindo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Duck Vaccines Industry Chain Analysis
7.2 Duck Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Duck Vaccines Production Mode & Process
7.4 Duck Vaccines Sales and Marketing
7.4.1 Duck Vaccines Sales Channels
7.4.2 Duck Vaccines Distributors
7.5 Duck Vaccines Customers
8 Duck Vaccines Market Dynamics
8.1 Duck Vaccines Industry Trends
8.2 Duck Vaccines Market Drivers
8.3 Duck Vaccines Market Challenges
8.4 Duck Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Duck Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Duck Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Duck Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Duck Vaccines Sales (M Units) of Key Manufacturers (2018-2024)
Table 5. Global Duck Vaccines Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Duck Vaccines Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Duck Vaccines Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Duck Vaccines Average Price (USD/K Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Duck Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Duck Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Duck Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Duck Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Duck Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duck Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Duck Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Duck Vaccines Sales by Region (2018-2024) & (M Units)
Table 18. Global Duck Vaccines Sales Market Share by Region (2018-2024)
Table 19. Global Duck Vaccines Sales by Region (2024-2029) & (M Units)
Table 20. Global Duck Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global Duck Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Duck Vaccines Revenue Market Share by Region (2018-2024)
Table 23. Global Duck Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Duck Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America Duck Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Duck Vaccines Sales by Country (2018-2024) & (M Units)
Table 27. North America Duck Vaccines Sales by Country (2024-2029) & (M Units)
Table 28. North America Duck Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Duck Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Duck Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Duck Vaccines Sales by Country (2018-2024) & (M Units)
Table 32. Europe Duck Vaccines Sales by Country (2024-2029) & (M Units)
Table 33. Europe Duck Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Duck Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Duck Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Duck Vaccines Sales by Region (2018-2024) & (M Units)
Table 37. Asia Pacific Duck Vaccines Sales by Region (2024-2029) & (M Units)
Table 38. Asia Pacific Duck Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Duck Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Duck Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Duck Vaccines Sales by Country (2018-2024) & (M Units)
Table 42. Latin America Duck Vaccines Sales by Country (2024-2029) & (M Units)
Table 43. Latin America Duck Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Duck Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Duck Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Duck Vaccines Sales by Country (2018-2024) & (M Units)
Table 47. Middle East & Africa Duck Vaccines Sales by Country (2024-2029) & (M Units)
Table 48. Middle East & Africa Duck Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Duck Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Duck Vaccines Sales (M Units) by Type (2018-2024)
Table 51. Global Duck Vaccines Sales (M Units) by Type (2024-2029)
Table 52. Global Duck Vaccines Sales Market Share by Type (2018-2024)
Table 53. Global Duck Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global Duck Vaccines Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Duck Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Duck Vaccines Revenue Market Share by Type (2018-2024)
Table 57. Global Duck Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global Duck Vaccines Price (USD/K Unit) by Type (2018-2024)
Table 59. Global Duck Vaccines Price (USD/K Unit) by Type (2024-2029)
Table 60. Global Duck Vaccines Sales (M Units) by Application (2018-2024)
Table 61. Global Duck Vaccines Sales (M Units) by Application (2024-2029)
Table 62. Global Duck Vaccines Sales Market Share by Application (2018-2024)
Table 63. Global Duck Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global Duck Vaccines Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Duck Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Duck Vaccines Revenue Market Share by Application (2018-2024)
Table 67. Global Duck Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global Duck Vaccines Price (USD/K Unit) by Application (2018-2024)
Table 69. Global Duck Vaccines Price (USD/K Unit) by Application (2024-2029)
Table 70. Boehringer Ingelheim Corporation Information
Table 71. Boehringer Ingelheim Description and Business Overview
Table 72. Boehringer Ingelheim Duck Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 73. Boehringer Ingelheim Duck Vaccines Product
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. CEVA Corporation Information
Table 76. CEVA Description and Business Overview
Table 77. CEVA Duck Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 78. CEVA Duck Vaccines Product
Table 79. CEVA Recent Developments/Updates
Table 80. CAHIC Corporation Information
Table 81. CAHIC Description and Business Overview
Table 82. CAHIC Duck Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 83. CAHIC Duck Vaccines Product
Table 84. CAHIC Recent Developments/Updates
Table 85. Ringpu Biology Corporation Information
Table 86. Ringpu Biology Description and Business Overview
Table 87. Ringpu Biology Duck Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 88. Ringpu Biology Duck Vaccines Product
Table 89. Ringpu Biology Recent Developments/Updates
Table 90. Yebio Corporation Information
Table 91. Yebio Description and Business Overview
Table 92. Yebio Duck Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 93. Yebio Duck Vaccines Product
Table 94. Yebio Recent Developments/Updates
Table 95. Harbin Veterinary Research Institute Corporation Information
Table 96. Harbin Veterinary Research Institute Description and Business Overview
Table 97. Harbin Veterinary Research Institute Duck Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 98. Harbin Veterinary Research Institute Duck Vaccines Product
Table 99. Harbin Veterinary Research Institute Recent Developments/Updates
Table 100. Merck Animal Health Corporation Information
Table 101. Merck Animal Health Description and Business Overview
Table 102. Merck Animal Health Duck Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 103. Merck Animal Health Duck Vaccines Product
Table 104. Merck Animal Health Recent Developments/Updates
Table 105. Zoetis Corporation Information
Table 106. Zoetis Description and Business Overview
Table 107. Zoetis Duck Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 108. Zoetis Duck Vaccines Product
Table 109. Zoetis Recent Developments/Updates
Table 110. Elanco Corporation Information
Table 111. Elanco Description and Business Overview
Table 112. Elanco Duck Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 113. Elanco Duck Vaccines Product
Table 114. Elanco Recent Developments/Updates
Table 115. FATRO Corporation Information
Table 116. FATRO Description and Business Overview
Table 117. FATRO Duck Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 118. FATRO Duck Vaccines Product
Table 119. FATRO Recent Developments/Updates
Table 120. CAVAC Corporation Information
Table 121. CAVAC Description and Business Overview
Table 122. CAVAC Duck Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 123. CAVAC Duck Vaccines Product
Table 124. CAVAC Recent Developments/Updates
Table 125. Vaksindo Corporation Information
Table 126. Vaksindo Description and Business Overview
Table 127. Vaksindo Duck Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 128. Vaksindo Duck Vaccines Product
Table 129. Vaksindo Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Duck Vaccines Distributors List
Table 133. Duck Vaccines Customers List
Table 134. Duck Vaccines Market Trends
Table 135. Duck Vaccines Market Drivers
Table 136. Duck Vaccines Market Challenges
Table 137. Duck Vaccines Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Duck Vaccines
Figure 2. Global Duck Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Duck Vaccines Market Share by Type in 2022 & 2029
Figure 4. Attenuated Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global Duck Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Duck Vaccines Market Share by Application in 2022 & 2029
Figure 8. Avian Influenza Vaccine
Figure 9. Newcastle Disease Vaccine
Figure 10. Other
Figure 11. Global Duck Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Duck Vaccines Market Size (2018-2029) & (US$ Million)
Figure 13. Global Duck Vaccines Sales (2018-2029) & (M Units)
Figure 14. Global Duck Vaccines Average Price (USD/K Unit) & (2018-2029)
Figure 15. Duck Vaccines Report Years Considered
Figure 16. Duck Vaccines Sales Share by Manufacturers in 2022
Figure 17. Global Duck Vaccines Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Duck Vaccines Players: Market Share by Revenue in 2022
Figure 19. Duck Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Duck Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Duck Vaccines Sales Market Share by Country (2018-2029)
Figure 22. North America Duck Vaccines Revenue Market Share by Country (2018-2029)
Figure 23. the United States Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Duck Vaccines Sales Market Share by Country (2018-2029)
Figure 26. Europe Duck Vaccines Revenue Market Share by Country (2018-2029)
Figure 27. Germany Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. UK Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Duck Vaccines Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Duck Vaccines Revenue Market Share by Region (2018-2029)
Figure 34. China Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Duck Vaccines Sales Market Share by Country (2018-2029)
Figure 44. Latin America Duck Vaccines Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Duck Vaccines Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Duck Vaccines Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Duck Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Duck Vaccines by Type (2018-2029)
Figure 54. Global Revenue Market Share of Duck Vaccines by Type (2018-2029)
Figure 55. Global Duck Vaccines Price (USD/K Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Duck Vaccines by Application (2018-2029)
Figure 57. Global Revenue Market Share of Duck Vaccines by Application (2018-2029)
Figure 58. Global Duck Vaccines Price (USD/K Unit) by Application (2018-2029)
Figure 59. Duck Vaccines Value Chain
Figure 60. Duck Vaccines Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed